Mads Holten-Andersen

2.5k total citations
37 papers, 1.1k citations indexed

About

Mads Holten-Andersen is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Mads Holten-Andersen has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Mads Holten-Andersen's work include Protease and Inhibitor Mechanisms (17 papers), Peptidase Inhibition and Analysis (16 papers) and Obesity, Physical Activity, Diet (7 papers). Mads Holten-Andersen is often cited by papers focused on Protease and Inhibitor Mechanisms (17 papers), Peptidase Inhibition and Analysis (16 papers) and Obesity, Physical Activity, Diet (7 papers). Mads Holten-Andersen collaborates with scholars based in Denmark, Norway and Netherlands. Mads Holten-Andersen's co-authors include Hans Jørgen Nielsen, Nils Brünner, Gillian Murphy, Ross W. Stephens, I. J. Christensen, Ib Jarle Christensen, Anne‐Sofie Schrohl, John A. Foekens, Vibeke Jensen and N. Brünner and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Clinical Nutrition and Clinical Cancer Research.

In The Last Decade

Mads Holten-Andersen

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mads Holten-Andersen Denmark 17 660 565 246 161 133 37 1.1k
Marta A. Crispens United States 25 498 0.8× 296 0.5× 568 2.3× 64 0.4× 52 0.4× 62 1.8k
Cecilie L. Bager Denmark 16 267 0.4× 201 0.4× 270 1.1× 99 0.6× 39 0.3× 35 937
Changqing Yang China 12 198 0.3× 306 0.5× 367 1.5× 194 1.2× 55 0.4× 28 870
Francesco La Rocca Italy 20 253 0.4× 308 0.5× 592 2.4× 46 0.3× 218 1.6× 62 1.3k
Jan Kornafel Poland 16 411 0.6× 144 0.3× 246 1.0× 26 0.2× 67 0.5× 73 832
Jens Voortman Netherlands 19 358 0.5× 151 0.3× 427 1.7× 61 0.4× 93 0.7× 41 890
Johannes C. Kirchheimer Austria 21 304 0.5× 815 1.4× 286 1.2× 223 1.4× 484 3.6× 41 1.2k
Damon Disch United States 10 544 0.8× 191 0.3× 235 1.0× 18 0.1× 45 0.3× 17 1.1k
Ewan Brown United Kingdom 18 501 0.8× 238 0.4× 510 2.1× 68 0.4× 19 0.1× 30 1.2k
Yuji Takei Japan 21 339 0.5× 143 0.3× 394 1.6× 36 0.2× 36 0.3× 75 1.2k

Countries citing papers authored by Mads Holten-Andersen

Since Specialization
Citations

This map shows the geographic impact of Mads Holten-Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mads Holten-Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mads Holten-Andersen more than expected).

Fields of papers citing papers by Mads Holten-Andersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mads Holten-Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mads Holten-Andersen. The network helps show where Mads Holten-Andersen may publish in the future.

Co-authorship network of co-authors of Mads Holten-Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Mads Holten-Andersen. A scholar is included among the top collaborators of Mads Holten-Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mads Holten-Andersen. Mads Holten-Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konijnenberg, Carolien, Adrian McCann, Per Magne Ueland, et al.. (2025). Infant vitamin B12 status and its predictors – cross-sectional baseline results from an ongoing randomized controlled trial. American Journal of Clinical Nutrition. 122(3). 803–810.
2.
Leonhardt, Marja, et al.. (2025). Mental health and energy drink consumption among Norwegian adolescents; a cross-sectional study. BMC Public Health. 25(1). 2158–2158.
4.
Bakken, Kjersti, et al.. (2023). Inadequate Iodine Intake in Mothers of Young Children in Innlandet County, Norway. Current Developments in Nutrition. 7(3). 100047–100047. 5 indexed citations
5.
Bakken, Kjersti, et al.. (2023). Iodine Nutrition in Children ≤2 years of Age in Norway. Journal of Nutrition. 153(11). 3237–3246. 2 indexed citations
6.
Bakken, Kjersti, et al.. (2022). Modifiable and non-modifiable risk factors for obstetric anal sphincter injury in a Norwegian Region: a case–control study. BMC Pregnancy and Childbirth. 22(1). 277–277. 5 indexed citations
7.
Strand, Tor A., et al.. (2021). Social determinants and changes in energy drink consumption among adolescents in Norway, 2017–2019: a cross-sectional study. BMJ Open. 11(8). e049284–e049284. 15 indexed citations
8.
Holten-Andersen, Mads, et al.. (2020). Vitamin D Status and Its Determinants in a Paediatric Population in Norway. Nutrients. 12(5). 1385–1385. 5 indexed citations
9.
Schwinger, Catherine, et al.. (2020). Health-Related Behaviors in Adolescents Mediate the Association between Subjective Social Status and Body Mass Index. International Journal of Environmental Research and Public Health. 17(19). 7307–7307. 4 indexed citations
10.
Fossum, Ingrid Nesdal, et al.. (2018). Consumption of energy drinks among adolescents in Norway: a cross-sectional study. BMC Public Health. 18(1). 1391–1391. 40 indexed citations
11.
Holten-Andersen, Mads, Hans Jørgen Nielsen, Steen Sørensen, et al.. (2006). Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer. European Journal of Cancer. 42(12). 1889–1896. 39 indexed citations
12.
Holten-Andersen, Mads, Ulla Hansen, Nils Brünner, et al.. (2004). Localization of tissue inhibitor of metalloproteinases 1 (TIMP‐1) in human colorectal adenoma and adenocarcinoma. International Journal of Cancer. 113(2). 198–206. 44 indexed citations
13.
Holten-Andersen, Mads, I. J. Christensen, Mef Nilbert, et al.. (2003). Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival. European Journal of Cancer. 40(1). 64–72. 46 indexed citations
14.
Schrohl, Anne‐Sofie, Ib Jarle Christensen, Anders N. Pedersen, et al.. (2003). Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer. Molecular & Cellular Proteomics. 2(3). 164–172. 62 indexed citations
16.
Schrohl, Anne‐Sofie, Mads Holten-Andersen, Fred C.G.J. Sweep, et al.. (2003). Tumor Markers. Molecular & Cellular Proteomics. 2(6). 378–387. 63 indexed citations
17.
Krarup, Henrik, et al.. (2003). Effect of antiviral therapy on markers of fibrogenesis in patients with chronic hepatitis C. Journal of Hepatology. 38. 159–160. 6 indexed citations
18.
Holten-Andersen, Mads, et al.. (2003). Evaluation of Sample Handling in Relation to Levels of Tissue Inhibitor of Metalloproteinases-1 Measured in Blood by Immunoassay. The International Journal of Biological Markers. 18(3). 170–176. 16 indexed citations
19.
Jensen, Morten Krogh, Mads Holten-Andersen, Rikke Riisbro, et al.. (2003). Elevated plasma levels of TIMP‐1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disorders. European Journal Of Haematology. 71(5). 377–384. 17 indexed citations
20.
Holten-Andersen, Mads, Gillian Murphy, Hans Jørgen Nielsen, et al.. (1999). Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. British Journal of Cancer. 80(3-4). 495–503. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026